Zimbabwe - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Zimbabwe Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases rose 6.5% year on year. In 2019, the country was number 62 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases with 565 Cases. Zimbabwe is overtaken by Papua New Guinea, which was number 61 at 580 Cases and is followed by Nepal with 558 Cases. India lead the ranking with 66,255 Cases in 2019, an increase of 13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia recorded the worst performance at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 565.00 |
| 2018 | 537.00 |
| 2017 | 474.00 |
| 2016 | 572.00 |
| 2015 | 468.00 |
How does Zimbabwe rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 61 |
#61
Papua New Guinea
|
580 | 2019 | +34.0 % | +12.6 % | View data | |
| 62 |
#62
Zimbabwe
|
565 | 2019 | +5.2 % | +6.5 % | View data | |
| 65 |
#65
Tanzania
|
534 | 2019 | +18.9 % | +0.7 % | View data | |